BIOA
NASDAQ · Pharmaceuticals
Bioage Labs Inc
$22.10
-0.22 (-0.99%)
Open$22.36
Previous Close$22.32
Day High$22.79
Day Low$22.08
52W High$24.00
52W Low$4.07
Volume—
Avg Volume481.3K
Market Cap923.28M
P/E Ratio—
EPS$-2.40
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-40.5% upside
Current
$22.10
$22.10
Target
$13.14
$13.14
$9.99
$13.14 avg
$19.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 11.81M | 148.13M | 155.08M |
| Net Income | -105,884,923 | 34.83M | 38.64M |
| Profit Margin | -896.1% | 23.5% | 24.9% |
| EBITDA | -121,598,676 | 58.57M | 58.31M |
| Free Cash Flow | — | 41.37M | 59.47M |
| Rev Growth | — | -6.9% | -7.9% |
| Debt/Equity | 0.01 | 0.90 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |